GMO Click Securities Co., Ltd, an online securities company and part of Japanese IT giant GMO Internet, announced this Tuesday that following its Ordinary General Meeting of Shareholders, a new director has been appointed.
Specifically, the retail brokerage unit of the company has appointed Oda Hiroyuki as a director, effective from today, the 17th of March, 2020. At the same time, Shuji Takano, a managing director of the firm, will be retiring from his position.
According to the information provided by the Tokyo based company, Takano is leaving the position of managing director because his term has expired. The change is also effective from this Tuesday.
Hiroyuki has been with the Group since October of 2006, initially joining GMO Internet Securities Co., Ltd., which is now GMO Click Securities. In October of 2012, he was promoted to the position of Compliance Department Manager.
The Rising Star of the DeFi Project, GIBXSwap, Passes CertiK Security AuditGo to article >>
In exactly three years in this role, he went on to become the Marketing Office Manager for the company. Less than a year later, he was named the General Manager of the Compliance Department, which is his current position.
GMO Click reports solid FX trading in February
Today’s update follows on from GMO Click reporting solid trading volumes during February, joining a growing list of trading providers to have seen robust trading last month.
As Finance Magnates reported, during February, over the counter (OTC) foreign exchange (forex) margin trading, which is executed through FX Neo, saw an uptick on a monthly comparison. In particular, the monthly trading value for OTC FX margin was ¥75.3 trillion ($701.5 billion).
This is higher than the monthly trading value achieved in the previous month, which had a monthly trading value of ¥59.3 trillion, by 27.0 percent. Last month’s trading value has not only increased on a monthly perspective, but it has also risen on a yearly comparison. In particular, February of 2020’s FX trading value is up by 49.3 percent year-on-year.